Filing Overview
InterCure Ltd. filed a Form 6-K on June 12, 2023, covering the month of June 2023. The filing identifies the company as an Israeli foreign private issuer filing annual reports on Form 20-F.
Business Context and Reporting Period
The filing is a cover report under Rule 13a-16 or 15d-16 and references a press release dated June 9, 2023. The submitted text does not include the substance of that press release.
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes and Outlook
The filing text does not provide information regarding changes versus a prior comparable period, guidance, outlook, management commentary, risks, contingencies, or unusual items.
Exhibit
- Exhibit 99.1: Press release dated June 9, 2023; the exhibit content is not included in the provided filing text.
Investor Verification Items
- Obtain and review Exhibit 99.1 for the underlying announcement and any financial or operational details.
- Verify whether the press release contains guidance, financing information, material risks, or other reportable developments.
- Consult InterCure’s applicable Form 20-F and subsequent filings for complete financial results and liquidity information.